Identifying biomarkers for diagnosing sepsis in the emergency room
Official title: Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
Run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · NCT06178822 · Data updated 2026-11-12
This study is trying to find out if certain immune responses can help doctors spot sepsis in patients with infections when they arrive at the emergency room.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 3300 (estimated) |
| Sponsor | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Academic / other |
| Locations | 3 sites (Almere Stad, Flevoland and 2 other locations) |
| Status | Recruiting |
| Started | October 25, 2022 |
| Main results expected | October 1, 2026 |
| Study ends | October 1, 2026 |
| Registry record updated | October 2, 2025 |
| Trial ID | NCT06178822 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 years or older who present to the emergency department with a clinical suspicion of infection.
✕Probably not a fit
Patients who do not provide informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to compare the immune responses of patients with and without sepsis who present to the emergency department with suspected infections. It seeks to identify immune response abnormalities that may indicate an increased risk of developing sepsis in patients initially presenting without it. Additionally, the study will assess the long-term cognitive and physical effects of sepsis on patients after their admission. The research will utilize the SOFA score to define sepsis and will adapt the assessment of respiratory function for emergency settings.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic methods for sepsis, enabling timely and effective treatment for patients.
How similar studies have gone: Other studies have explored biomarkers for sepsis diagnosis, but this specific approach focusing on immune responses in the emergency setting is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years or higher * Presentation at the Emergency Department (ED) * Clinical suspicion of infection or earlier confirmed infection * Modified Early Warning Score (MEWS) of 2 or higher Exclusion Criteria: * No informed consent given
Where it's running
-
Amsterdam UMC, location VUMC
Amsterdam, North Holland, Netherlands Recruiting -
Amsterdam UMC, location AMC
Amsterdam, North Holland, Netherlands Recruiting -
Flevoziekenhuis
Almere Stad, Flevoland, Netherlands Not yet recruiting
Study contacts
- Principal investigator: Willem Joost Wiersinga, MD, PhD — Amsterdam UMC, location AMC
- Study coordinator: Oren Turgman, MD, MsC
- Email: biosep@amsterdamumc.nl
- Phone: 0205669111
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Reducing unnecessary vancomycin use in children with suspected sepsis
This study is testing a new approach to see if better guidelines and education can help doctors use less vancomycin in children suspected of having sepsis, which could lower the risk of kidney problems.
-
Personalized care approach for patients with suspected sepsis
This study is testing new ways to diagnose sepsis in about 1500 adults who show signs of it when they arrive at the emergency department, to help create more personalized treatment plans.
-
Non-invasive hemodynamic guidance for sepsis care on medical wards
This trial tests whether guiding fluid and vasopressor therapy for sepsis using non-invasive hemodynamic measurements works better than standard care.
-
Personalized Fluid Resuscitation in the Emergency Department
This pilot test checks if a quick, non-invasive stroke-volume assessment can help ED doctors tailor IV fluids for septic patients with low blood pressure.
-
Discordance between capillary refill time and oxygen use in septic shock
This study tests whether some septic shock patients can have a normal capillary refill time but still lack tissue oxygen use, to see if that mismatch relates to 28-day survival.
-
Targeting upper-normal magnesium to see if norepinephrine needs drop in septic shock
This trial tests whether keeping magnesium levels at the upper end of normal can reduce the amount and duration of norepinephrine needed in adults with septic shock.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.